Welcome to our dedicated page for Tri Pointe Homes SEC filings (Ticker: TPH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Trying to locate how many controlled lots Tri Pointe Homes is carrying this quarter or whether cancellation rates are rising? Homebuilder disclosures run hundreds of pages and the details on land inventory, backlog and debt can be buried deep in footnotes. Our AI-powered platform surfaces those hard-to-find metrics instantly, so you can stop scrolling and start understanding.
Every filing—whether it’s a Tri Pointe Homes quarterly earnings report 10-Q filing that breaks down regional gross margins or an 8-K material events explained notice for a new credit facility—is captured the moment it hits EDGAR. Stock Titan then produces concise, plain-English summaries and red-flags key data points. Need to watch executive sentiment? Get real-time alerts on Tri Pointe Homes insider trading Form 4 transactions and track patterns in Tri Pointe Homes executive stock transactions Form 4 before market moves.
- 10-K Annual Report: See land pipeline health, lot counts and market-by-market performance—our AI delivers a Tri Pointe Homes annual report 10-K simplified view in minutes.
- 10-Q Quarterly Report: Compare backlog conversion and average selling prices with our Tri Pointe Homes earnings report filing analysis.
- 8-K: Follow acquisition announcements and debt amendments with Tri Pointe Homes 8-K material events explained.
- Form 4: Monitor Tri Pointe Homes Form 4 insider transactions real-time to spot insider confidence.
- Proxy Statement: Quickly review Tri Pointe Homes proxy statement executive compensation without wading through tables.
Whether you’re assessing cycle timing, evaluating margins or simply understanding Tri Pointe Homes SEC documents with AI, Stock Titan turns exhaustive filings into actionable knowledge, complete with real-time updates and expert commentary.
TriSalus Life Sciences, Inc. (TLSI) filed an 8-K to report the successful completion of its exchange offer and related consent solicitation for its Series A Convertible Preferred Stock. The offer expired 23 Jul 2025; 3,551,502 preferred shares, or 98.82% of the class, were validly tendered. Holders will receive common shares equal to the sum of Liquidation Preference plus Accrued Dividends through 10 Aug 2027, divided by $4.00 per share. Settlement is targeted on or before 1 Aug 2025.
The overwhelming participation satisfied the required majority consent, allowing the company to adopt a Preferred Stock Amendment filed 24 Jul 2025 with the Delaware Secretary of State. The amendment authorizes TriSalus to mandatorily convert any remaining preferred shares after offer closing into common stock using the same exchange value, thereby eliminating the preferred class and its dividend obligations.
Key 8-K items invoked: 3.03 (material modification of rights), 5.03 (charter amendment), 5.07 (shareholder vote), 8.01 (other events). Exhibits include the amendment (3.1) and a press release (99.1) detailing final results.
Synchrony Financial (SYF) has filed a preliminary prospectus supplement for two new fixed-to-floating senior note tranches (sizes and coupons still TBD). The notes carry an initial fixed rate through first call (180 days post-issue) and then switch to a floating rate of Compounded SOFR + spread; neither tranche will be guaranteed by subsidiaries and both are senior unsecured, ranking pari-passu with $4.4 bn of existing senior debt (post July 2025 $1 bn repayment) and structurally subordinated to $92.1 bn of subsidiary liabilities. Optional redemption is allowed at make-whole or par (see schedule). Proceeds are earmarked for general corporate purposes, potentially downstreamed to Synchrony Bank.
Key financials underscore ample capacity to absorb the issuance:
- 6M 2025 net earnings $1.72 bn (-11% YoY) on net interest income $8.99 bn (+2%).
- Provision for credit losses $2.64 bn (-26% YoY) after elevated 2024 levels.
- Deposits $82.3 bn fund 84% of assets; cash & equivalents rose to $19.5 bn.
- Total assets $120.5 bn; equity $17.0 bn.